Home Featured Page 312

Featured

Latest

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

New Research Compares Placebo and Psychedelic Microdosing Benefits

Psychedelic Business News Spotlight: February 5, 2021

2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month

Interview With Dr. Hyder A. Khoja

Interview With Yaron Conforti, Novamind

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275...

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results...

Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider...

EDITOR PICKS

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

New Research Compares Placebo and Psychedelic Microdosing Benefits

Psychedelic Business News Spotlight: February 5, 2021

2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month

Interview With Dr. Hyder A. Khoja

Interview With Yaron Conforti, Novamind

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275...

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results...

Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider...

EDITOR PICKS

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

No Promises and No Goals

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY